SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT)

The current price of 0LC7 is 5.10 USD — it has decreased by 2.20% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) stocks are traded under the ticker 0LC7.

SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.

0LC7 stock is 3.47% volatile and has beta coefficient of 1.18. Check out the list of the most volatile stocks — is SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) there?

0LC7 earnings for the last quarter are −1.43 USD per share, whereas the estimation was −1.14 USD resulting in a −25.44% surprise. The estimated earnings for the next quarter are −1.14 USD per share. See more details about SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) earnings.

SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) revenue for the last quarter amounts to ‪3.76 M‬ USD despite the estimated figure of ‪3.94 M‬ USD. In the next quarter revenue is expected to reach ‪2.00 M‬ USD.

Yes, you can track SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) financials in yearly and quarterly reports right on TradingView.

0LC7 stock has fallen by 8.40% compared to the previous week, the month change is a 18.24% fall, over the last year SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) has showed a 84.14% increase.

Today SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) has the market capitalization of ‪136.31 M‬, it has decreased by 10.25% over the last week.

No, 0LC7 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, 0LC7 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) stock right from TradingView charts — choose your broker and connect to your account.

0LC7 reached its all-time high on Jan 20, 2021 with the price of 151.90 USD, and its all-time low was 2.25 USD and was reached on Oct 16, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 26, 2024, the company has 68.00 employees. See our rating of the largest employees — is SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) stock shows the sell signal. See more of SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) future price: according to them, 0LC7 price has a max estimate of 37.00 USD and a min estimate of 12.00 USD. Read a more detailed SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) forecast: see what analysts think of SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) EBITDA is ‪−124.25 M‬ USD, and current EBITDA margin is ‪−1.25 K‬%. See more stats in SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) financial statements.